Key indicators: single-crystal X-ray study; T = 292 K; mean (C-C) = 0.002 Å; R factor = 0.045; wR factor = 0.129; data-to-parameter ratio = 13.5.
Related literature
The title compound may be used as a precursor for obtaining bioactive molecules, see: Bellarosa et al. (1996) (2005, 2006, 2007, 2008) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). (Moneam et al., 2004 and Bodke et al., 2003) . On the other hand, heterocycles containing an imidazolone nucleus also exhibit various biological activities. Several of them have shown good antibacterial, antifungal activities or are used as leukotriene B4 receptor antagonist and potassium channel openers (Palacios et al., 2007 and Duval et al., 2005 , Teimouria et al., 2006 . The introduction of an imidazolone ring to the benzofuro[3,2-d]pyrimidin-4(3H)-one system is expected to influence the biological activities significantly. As a part of our ongoing investigations on the preparation of derivatives of heterocyclic compounds (Hu et al., 2005 (Hu et al., , 2006 (Hu et al., , 2007 (Hu et al., , 2008 , we have synthesized and structurally characterized the title compound, and here we report its crystal structure ( Fig. 1 ).
In the crystal structure of the title compound, all ring atoms of imidazo[1,2-a]benzo [4, 5] 
The title compound was obtained in excellent yield via aza-Wittig reaction. Crystals suitable for single-crystal X-ray diffraction were obtained by recrystallization from a mixed solvent of ethanol and dichloromethane (1:2 v/v) at room temperature.
Refinement
All H-atoms were found in a difference map but positioned with idealized geometry and refined with U iso (H)= 1.5U eq (C) for methyl H atoms and U iso (H) =1.2U eq (C) for all other H atoms using a riding model with C-H ranging from 0.93Å to 0.97Å. Figures   Fig. 1 . The molecular structure of the title compound, showing the atom-labeling scheme. Displacement ellipsoids are at the 50% probability level. 
Special details

